Category Archives: Health

Latest From Health

BIO Launches New Website Holding Insurers Accountable: Un-surance.com

medical_research

BIO is undertaking an aggressive effort to promote the value of biopharmaceutical innovations and ensure that all patients have access to the drugs they need. A vital component of this campaign is holding insurers and their allies accountable for standing in the way of that access. For months, we’ve blown the whistle on their discriminatory practices, high cost-sharing and cost-shifting, and their blatant falsehoods on what’s driving their premium increases, and today, we’re introducing a Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial

health care, medicine

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which highlighted new findings from a paper published in Nature. They shared exciting news of positive early trial results for a potential new Alzheimer’s treatment. “Overall this is the best news that we’ve had in my 25 years doing Alzheimer’s clinical research and it brings new hope for patients and families most affected by the disease,” said one of the study’s Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

ICYMI: Making Biopharmaceutical Innovation a Priority of the Next Administration

health care, medicine

Last week, Astellas Americas President Jim Robinson wrote an op-ed in Forbes exploring, “How The Next Administration Embraces Medical Invention.” He calls for “understanding, appreciation, and investment” in the complex sciences curing cancers and debilitating conditions. Robinson points out that we are living in an age where the death rates from cardiovascular disease have dropped, where there is a cure for hepatitis C, and the five-year survival rate for cancer continues to climb ever higher Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

ICYMI: Peter Pitts Weighs in on Drug Price Debate

health care, medicine

This week in the Sacramento Bee, Peter J. Pitts, a former U.S. Food and Drug Administration associate commissioner and now president of the Center for Medicine in the Public Interest, wrote an op-ed regarding the ongoing drug pricing debate titled “Rising Drug Prices The Fault Of Insurers, Not Drug Companies.” Pitts lists two essential factors that are often overlooked in this discussion: First, the very real financial pain many Americans feel at the pharmacy counter Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Shaping the Future of BIO 2017: Tips for Getting the Best Sessions and Speakers on Stage in San Diego

Crowd - Lean in

As the summer begins winding down and the year ahead looms ever closer, it’s time to get ready for BIO 2017! We need your help in shaping the future of the BIO education program. The annual Call for Sessions and Speakers opens September 15 and runs through October 13. Our survey results and event feedback indicate that last year’s program was the best ever with record breaking attendance and the emergence of breakthrough ideas discussed Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,